Company Filing History:
Years Active: 2005-2007
Title: The Innovative Mind of Scott B. Mohler
Introduction
Scott B. Mohler is a notable inventor based in Chicago, IL, who has made significant contributions to the field of pharmaceutical chemistry. With a total of four patents to his name, he has developed innovative solutions aimed at addressing critical health issues, including inflammation and cancer.
Latest Patents
Among his latest patents is "Substituted Pyrazolyl Compounds for the Treatment of Inflammation." This invention focuses on substituted pyrazolyl derivatives and their use in pharmaceutical compositions for treating inflammation-associated disorders such as arthritis. Another pivotal patent is "Heteroarylakanoic Acids as Integrin Receptor Antagonists." This work describes a class of compounds that selectively antagonize certain integrin receptors without affecting the IIb/IIIa integrin, presenting a considerable advancement in therapeutic options.
Career Highlights
Scott is associated with Pharmacia Corporation, where he has honed his skills and contributed to various research projects. His innovative work has garnered attention in the scientific community, paving the way for advancements in drug development.
Collaborations
At Pharmacia Corporation, Scott collaborates with esteemed colleagues such as Michael B. Tollefson and Srinivasan Raj Nagarajan. Together, they work towards pushing the boundaries of pharmaceutical research and developing new therapies.
Conclusion
With his impressive portfolio of patents and collaborations, Scott B. Mohler exemplifies the spirit of innovation. His dedication to addressing complex health challenges positions him as a significant figure in the realm of pharmaceutical inventions.